E-LIB Suche - Ergebnisse für: Sun, Xushan

1

Letter to the Editor: SMAC mimetics inhibit human T cell pr..:

Bourhis, Jean ; Sun, Xu-Shan ; Tao, Yungan
Cellular Immunology. 395-396 (2024) - p. 104772 , 2024

Link: https://doi.org/10.1016/..

2

Standard versus fractionated high-dose cisplatin plus radia..:

Borel, Christian ; Sun, Xu-Shan ; Coutte, Alexandre...
Radiotherapy and Oncology. 197 (2024) - p. 110329 , 2024

Link: https://doi.org/10.1016/..

3

Long-term Results from a Clinical Study of Xevinapant Plus ..:

TAO, Yungan ; Sun, Xu-Shan ; Pointreau, Yoann...
Future Oncology. 19 (2023) 26 - p. 1769-1776 , 2023

Link: https://doi.org/10.2217/..

4

Extended follow-up of a phase 2 trial of xevinapant plus ch..:

TAO, Yungan ; Sun, Xu-Shan ; Pointreau, Yoann...
European Journal of Cancer. 183 (2023) - p. 24-37 , 2023

Link: https://doi.org/10.1016/..

5

Cisplatin-based chemoradiation decreases telomerase-specifi..:

Boustani, Jihane ; Joseph, Elodie Lauret Marie ; Martin, Etienne...
BMC Immunology. 22 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

6

Impact of Neck Dissection in Head and Neck Squamous Cell Ca..:

Abu-Shama, Yazan ; Salleron, Julia ; Carsuzaa, Florent...
Cancers. 13 (2021) 10 - p. 2416 , 2021

Link: https://doi.org/10.3390/..

7

Avelumab–cetuximab–radiotherapy versus standards of care in..:

Tao, Yungan ; Aupérin, Anne ; Sun, Xushan...
European Journal of Cancer. 141 (2020) - p. 21-29 , 2020

Link: https://doi.org/10.1016/..

8

Concurrent cisplatin and dose escalation with intensity-mod..:

Tao, Yungan ; Auperin, Anne ; Blanchard, Pierre...
Radiotherapy and Oncology. 150 (2020) - p. 18-25 , 2020

Link: https://doi.org/10.1016/..

9

10-Year Locoregional Control with Postoperative External Be..:

Servagi Vernat, Stéphanie ; Khalifa, Jonathan ; Sun, Xu-Shan...
Cancers. 11 (2019) 6 - p. 849 , 2019

Link: https://doi.org/10.3390/..

10

Phase I/II and Pharmacokinetic Study of Intravenous Vinflun..:

Souquet, Pierre-Jean ; Krzakowski, Maciej ; Ramlau, Rodrig...
Clinical Lung Cancer. 11 (2010) 2 - p. 105-113 , 2010

Link: https://doi.org/10.3816/..

11

Extended follow-up of a phase 2 trial of xevinapant plus ch..:

Tao, Yungan ; Sun, Xu-Shan ; Pointreau, Yoann...
https://boris.unibe.ch/178901/. , 2023

Link: https://boris.unibe.ch/1..

12

Cisplatin-based chemoradiation decreases telomerase-specifi..:

Boustani, Jihane ; Joseph, Elodie, Lauret Marie ; Martin, Etienne...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12865-021-00429-5. , 2021

Link: https://inserm.hal.scien..

13

Cisplatin-based chemoradiation decreases telomerase-specifi..:

Boustani, Jihane ; Joseph, Elodie ; Martin, Etienne...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12865-021-00429-5. , 2021

Link: https://www.hal.inserm.f..

14

Cisplatin-based chemoradiation decreases telomerase-specifi..:

Boustani, Jihane ; Joseph, Elodie, Lauret Marie ; Martin, Etienne...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12865-021-00429-5. , 2021

Link: https://inserm.hal.scien..

15

Impact of Neck Dissection in Head and Neck Squamous Cell Ca..:

Abu-Shama, Yazan ; Salleron, Julia ; Carsuzaa, Florent...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13102416. , 2021

Link: https://hal.sorbonne-uni..